Activation of pDCs in tumor-draining lymph nodes or the presence of TGF-β results in the constitutive expression of the IDO immunosuppressive enzyme, which induces immune tolerance and facilitates tumor progression [190, 191]. Here, IDO1 is linked to neoplasm.